Clinical Trial Update: Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Avastin for corneal neovascularization has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Corneal Newvessels | Phase 3 | Status: COMPLETED